| Literature DB >> 31223600 |
Anup Singh1, Aru-Chhabra Handa1, Ritesh Sachdev2.
Abstract
INTRODUCTION: Pleomorphic adenomas are benign neoplasms of salivary glands. The simultaneous homolateral occurrence of these tumors in salivary glands is exceedingly rare. CASE REPORT: An adult female presenting to our OPD with the swelling of right-sided preauricular and submandibular regions was diagnosed with the pleomorphic adenoma based on fine needle aspiration cytology. The patient was subjected to the excision of both swellings under general anesthesia. Postoperative facial nerve functions were within normal limits and final histopathology confirmed pleomorphic adenoma involving both the sites. A pertinent detailed literature review of English and non-English studies was indicative of only nine such cases.Entities:
Keywords: Pleomorphic adenoma; Salivary glands; Surgical treatment; Synchronous
Year: 2019 PMID: 31223600 PMCID: PMC6556748
Source DB: PubMed Journal: Iran J Otorhinolaryngol ISSN: 2251-7251
Fig 1(A) Well-defined, slightly lobulated, firm mass lesion involving right parotid (arrow) and submandibular gland region (arrowhead) (encircled by dotted blue lines), (B) Intraoperative view showing the parotid bed, post superficial parotidectomy (arrow) with intact facial nerve, and submandibular gland tumour (arrowhead) in the process of removal, (C) Post-excision specimen indicating both the tumors excised in entirety with a surrounding cuff of normal tissue
Fig 2A 3.2×2.5-cm well-defined, slightly lobulated, iso to hypodense lesion with small areas of calcific foci involving the right superficial lobe of the parotid gland (white arrow) with mild focal heterogeneous contrast enhancement and central hypodense areas, and another 2.5×2.1 cm well defined, smoothly marginated iso to hypodense, poorly enhancing oval lesion involving right submandibular gland (arrowhead), causing smooth expansion of the gland (Tumor appearance is suggestive of benign etiology involving both the parotid and submandibular glands
Fig 3(A) Parotid gland: Two encapsulated biphasic tumor nodules with normal salivary gland tissue at the periphery. (H & E; 10×), (B) Parotid gland: Section from tumour showing the epithelial-myoepithelial component surrounded by chondromyxoid stroma. (H & E; 20×), (C) Submandibular gland: Section indicating encapsulated biphasic tumor surrounded by normal tissue, comprising predominantly of the epithelial-myoepithelial component. (H & E; 10×).
Literature Review
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 1. | 1956 | 62/F | Rt Parotid PA | 3×3 cm tumor in a superficial lobe of parotid x 11 years | NA | Rt SP | NA |
| 2. | 1966 | 58/F | Rt Parotid PA | 3×3×4 cm tumor in a superficial lobe of parotid×18 months | Soft tissue roentgenogram of face and neck | Rt SP | No recurrence after 21 months follow up |
| 3. | 1987 | 68/F | Rt SMG PA | 6.5×3×3 cm x 4 years4×3.5×2 cm dumbbell shaped deep lobe tumor ×10 years | CECT with sialography | Rt SMG tumor excision | NA |
| 4. | 1999 | 52/F h/o radiation exposure in childhood | Rt SMG PA | Both tumors 2×2 cm in size, present for 15-20 years | CECT | Concomitant Rt SP and SMG excision | NA |
| 5. | 2001 | 29/M | Rt Parotid PA | 34×25 mm for 3 years | CEMRI | Concomitant Rt SP and Lt SMG excision | NA |
| 6. | 2005 | 59/? | Rt Parotid PA | 3.4 cm for 5 years | CEMRI | Rt SP and Rt SMG excision | Complete excision, no recurrence at 2 years F/U |
| 7. | 2010 | 57/F | Lt Parotid PA | One year duration | ? | Lt SP and Lt SMG excision | ? |
| 8. | 2015 | 22/F | Rt (parotid + SMG) | Right side parotid PA – 2×2 cm for 1 year in 2005 Right SMG PA | CECT for 2nd and 3rd tumor | Rt SP | Complete excision. |
| 9. | 2017 | 30/M | Rt (SMG) | Rt SMG PA – 26 mm Lt Parotid PA – 22 mm The two tumors diagnosed 5 months apart | USG | Concomitant Rt SMG excision and Lt SP | Complete excision, |
(Rt- right, Lt- left, M- male, F- female, PA- pleomorphic adenoma, SMG-submandibular gland, NA- not available, SP-superficial parotidectomy, F/U- follow up, URI- upper respiratory tract infection, CECT–contrast-enhanced CT, CEMRI–contrast-enhanced magnetic resonance imaging, FNAC-fine needle aspiration cytology)